CompletedNot Applicable

Enhanced Recovery After Minimally Invasive Pancreaticoduodenectomy

Belgium210 participantsStarted 2016-03

Plain-language summary

This prospective observational cohort study aims to improve the postoperative course after minimally invasive pancreaticoduodenectomy (MIP) with stented pancreaticogastrostomy (sPG) for pancreatic head or peri-ampullary neoplasms. Patients are submitted to an enhanced recovery after surgery (ERAS) program with early enteral nutrition (EEN).

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients, male or female, who undergo MIP + sPG for a pancreatic or peri-ampullary tumor * Patients with and without pre-operative biliary drainage (for obstructive jaundice) * Patients fit for minimally invasive pancreaticoduodenectomy (MIP) * Informed consent signed Exclusion Criteria: * Pregnancy * MIP for pancreatic trauma * MIP for complications of endoscopic retrograde cholangio-pancreaticography (ERCP) * Reconstruction of the portal vein or superior mesenteric vein * Any arterial reconstruction at the time of surgery

What they're measuring

The incidence of severe complications

Timeframe: From date of pancreaticoduodenectomy until the date of discharge from hospital or date of death from any cause, whichever came first, assessed up to 3 months

Trial details

NCT IDNCT02671357

SponsorUniversity Hospital, Gasthuisberg

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-06

View on ClinicalTrials.gov More Pancreatic Neoplasms; Periampullary Neoplasms trials